Search research articles
Contact Us
Filters
Showing results (251-260 of 418) with videos related to
Page
of 42
Sort By:
The Journal of Investigative Dermatology
|
July 5, 2022
Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo
Amit G Pandya, John E Harris, Mark Lebwohl, et al.
Clinical and Experimental Dermatology
|
October 11, 2023
Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies
Mark Lebwohl, Lars Iversen, Liv Eidsmo, et al.
Dermatology and Therapy
|
June 23, 2023
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials
Saxon D Smith, Alexandros Stratigos, Matthias Augustin, et al.
The Journal of Clinical and Aesthetic Dermatology
|
November 12, 2015
Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy
Orit Markowitz, Michelle Schwartz, Eleanor Feldman, et al.
Journal of Drugs in Dermatology : JDD
|
August 9, 2023
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis
April W Armstrong, Rasika Reddy, Samiya Khan, et al.
Dermatology (Basel, Switzerland)
|
January 22, 2020
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry
Kristina Callis Duffin, Marc A Mason, Kenneth Gordon, et al.
Journal of the American Academy of Dermatology
|
November 5, 2013
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies
Jeremy Hugh, Abby S Van Voorhees, Rajiv I Nijhawan, et al.
Journal of Drugs in Dermatology : JDD
|
December 2, 2025
Maximizing a Focused Vitiligo Patient Visit: A Practical Approach
Abrar Qureshi, Hira Ghani, Seemal Desai, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study
Bruce Strober, Jerry Bagel, Mark Lebwohl, et al.
The Journal of Dermatological Treatment
|
October 21, 2016
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)
Kristian Reich, Craig Leonardi, Mark Lebwohl, et al.
Page
of 42
Search research articles
Search
Showing results (251-260 of 418) with videos related to
Sort By:
Page
of 42
The Journal of Investigative Dermatology
|
July 5, 2022
Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo
Amit G Pandya, John E Harris, Mark Lebwohl, et al.
Clinical and Experimental Dermatology
|
October 11, 2023
Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies
Mark Lebwohl, Lars Iversen, Liv Eidsmo, et al.
Dermatology and Therapy
|
June 23, 2023
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials
Saxon D Smith, Alexandros Stratigos, Matthias Augustin, et al.
The Journal of Clinical and Aesthetic Dermatology
|
November 12, 2015
Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy
Orit Markowitz, Michelle Schwartz, Eleanor Feldman, et al.
Journal of Drugs in Dermatology : JDD
|
August 9, 2023
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis
April W Armstrong, Rasika Reddy, Samiya Khan, et al.
Dermatology (Basel, Switzerland)
|
January 22, 2020
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry
Kristina Callis Duffin, Marc A Mason, Kenneth Gordon, et al.
Journal of the American Academy of Dermatology
|
November 5, 2013
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies
Jeremy Hugh, Abby S Van Voorhees, Rajiv I Nijhawan, et al.
Journal of Drugs in Dermatology : JDD
|
December 2, 2025
Maximizing a Focused Vitiligo Patient Visit: A Practical Approach
Abrar Qureshi, Hira Ghani, Seemal Desai, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study
Bruce Strober, Jerry Bagel, Mark Lebwohl, et al.
The Journal of Dermatological Treatment
|
October 21, 2016
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)
Kristian Reich, Craig Leonardi, Mark Lebwohl, et al.
Page
of 42